Navigation Links
Vioxx Not Safe Even For Short Term Use

Canadian researchers have found that Vioxx painkiller manufactured by Merck & Co would result in an increased risk of heart attack within two weeks after patients start taking the drug. // Statistics show that about 60 patients out of 239 elderly patients suffered from heart attacks within six to 13 days after they first started taking Vioxx. The study results are published in the Canadian Medical Association Journal. It was contrary to what Merck had previously told about the drug. It currently faces 11,500 Vioxx lawsuits. The company has been hit with three jury awards totaling $298.3 million, two of which involved short-term use of the painkiller. It is also associated with the death of a man who took the drug for a period of 30 days.

Linda Levesque, assistant professor of epidemiology at Queen's University in Kingston, Ontario said that it is highly dangerous for the first time users and they might suffer an attack in as little as two weeks. Merck is the fourth-biggest U.S. drug maker. It withdrew Vioxx in 2004 when the drug was proved to double the risk of heart attacks and strokes. It has set aside $970 million for legal costs and vows to fight each case rather than settle out of court. `Cases Easier to Win' Attorney Mark Lanier, the attorney for the drug company has already won two out of the three trials. Canadian researchers analyzed health records of 114,000 patients ages 66 and older who were prescribed painkillers, including Vioxx, Celebrex and ibuprofen. The study followed patients for about two and a half years, included 30,200 Vioxx users and 45,000 Celebrex users. Celebrex was not associated with any heart attacks but when patients started taking Vioxx it significantly increased the risk among patients. But it also diminished. But it is thought that the study would play a major role in contributing to making a better decision by the people.


'"/>




Page: 1

Related medicine news :

1. Increased Heart Attack Risk From Celebrex,Vioxx
2. Merck to pay $ 253.5 million to Vioxx victim family
3. Judgment In Favor Of Merck For Vioxx Drug
4. Could Long Tern Vioxx Users Suffer From Heart Attacks?
5. Doctor Grilled In Court For False Report About Vioxx Health Risk
6. Vioxx and Celebrex, now have alternatives
7. Merck in the Dock Due To Vioxx
8. A Stroke of Bad Luck for Vioxx
9. Arcoxia Slammed –Nothing Better Than Vioxx Says FD
10. Bad News for Short People
11. Painkillers Do Not Shorten Dying Patients Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... name in the pharmaceutical, medical and food industries. Aside from its GMP accreditation, ... (SIC), providing proof of successfully certified products, services and staff. , Validation Center ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ., the maker ... 2016 When Work Works Award for its use of effective workplace strategies to increase ... Works project administered by the Families and Work Institute (FWI) and the Society for ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... in intellectual property (IP) to its specialty academic programs. , Answering to the ... college’s existing certificate programs in health law, and environmental and land use law. ...
(Date:5/26/2016)... ... ... The Woodlands at John Knox Village , Florida’s first Life Plan ... and healing, celebrated its grand opening, today. The Woodlands at John Knox Village is ... Staff. , “This is an incredibly fulfilling time for John Knox Village as we ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... According to market research "Global ... Demand Forecast to 2022 - Industry Insights by Type ... by P&S Market Research, the global insulin delivery device ... it is expected to grow at a CAGR of ... segment is expected to witness the fastest growth at ...
(Date:5/25/2016)... CAMBRIDGE, England , May 25, 2016 /PRNewswire/ ... genomics company employing the precision of circulating tumour ... oncology, today announces the appointment of Professor ... will provide medical leadership across the clinical development ... that Inivata,s products help deliver significant improvements in ...
(Date:5/24/2016)... LONDON , May 24, 2016   ... primary endpoints demonstrating non-inferiority in overall bowel cleansing and superiority ... c leansing of ... http://photos.prnewswire.com/prnh/20130829/633895-a ) , Norgine B.V. today announced ... (1 litre PEG and ascorbate bowel preparation) versus standard 2 litre ...
Breaking Medicine Technology: